Friday, December 5, 2014

HanKore Environment price target raised to $1.27 by Maybank Kim Eng

Stock Name: HanKoreEnv
Company Name: HANKORE ENVIRONMENT TEC GRPLTD
Research House: Maybank Kim EngPrice Call: BUYTarget Price: 1.27



SINGAPORE (Dec 5): Maybank Kim Eng has raised its price target for HanKore Environment Technology from $1.14 to $1.27, still pegged at 30 times earnings but based on FY2016 projections.

Its recommendation remains "buy".

"HanKore has rallied 20% in the past month but we believe it is still a stock to own for the next 12 months," Maybank Kim Eng analyst Wei Bin said in a note today.

The water treatment firm is expected to benefit from favourable government policies in China, he noted.

Thursday, December 4, 2014

Nam Cheong cut to "hold", target cut to 39 cents by DBS Vickers

Stock Name: Nam Cheong
Company Name: NAM CHEONG LIMITED
Research House: DBS VickersPrice Call: HOLDTarget Price: 0.39



SINGAPORE (Dec 4): DBS Vickers has downgraded Nam Cheong to "hold" from "buy" and cut its price target from 60 cents to 39 cents, based on seven times projected FY2015 earnings.

The changes reflect a de-rating of the oil and gas sector on the back of weaker oil prices.

Parkway Life REIT kept at 'buy' with $2.66 target price by DBS

Stock Name: ParkwayLife Reit
Company Name: PARKWAYLIFE REIT
Research House: DBS VickersPrice Call: BUYTarget Price: 2.66



SINGAPORE (Dec 4): DBS Group Research is maintaining its "buy" call on Parkway Life REIT, with a price target of $2.66.

In a Dec 4 report, analysts Derek Tan and Andy Sim says P-Life REIT offers a good balance of visibility and growth. Asset recycling in Japan and future acquisitions are also potential re-rating catalysts for the stock.

P-Life REIT derives its income from a diversified base of healthcare-related properties with Singapore hospitals contributing 64% of revenues, Japan at 36% and Malaysia at less than 1%.

SingPost kept at 'buy' with lower target price $2.12 by DBS

Stock Name: SingPost
Company Name: SINGAPORE POST LIMITED
Research House: DBS VickersPrice Call: BUYTarget Price: 2.12



SINGAPORE (Dec 4): DBS Group Research is reiterating its "buy" call on Singapore Post, albeit with a lower price target of $2.12 from $2.18.

In a Dec 3 report, analyst Sachin Mittal says SingPost's acquisition of CP Holdings is earnings accretive and buying the last-mile delivery player would enhance its existing capabilities in Asia.

M1 kept at 'buy' with $4 target price by UOB-KayHian

Stock Name: M1
Company Name: M1 LIMITED
Research House: UOB KayHianPrice Call: BUYTarget Price: 4.00



SINGAPORE (Dec 4): UOB-KayHian is reiterating its "buy" call on M1 Limited with a price target of $4.

In a Dec 4 report, analyst Jonathan Koh expects pent-up demand from customers who were waiting for the larger form factor offered by iPhone 6 and 6 Plus to be unleashed and the alleviation of supply constraint to produce positive net addition for the telco in 4Q14.

Wednesday, December 3, 2014

Boustead Singapore cut to "hold", target reduced to $1.88 by CIMB

Stock Name: Boustead
Company Name: BOUSTEAD SINGAPORE LIMITED
Research House: CIMBPrice Call: HOLDTarget Price: 1.88



SINGAPORE (Dec 3): CIMB has downgraded Boustead Singapore to "hold" from "add" and cut its price target from $2.06 to $1.88, based on a revised sum-of-parts valuation.

The sharp fall in oil prices over the last few months will mean fewer projects for the engineering firm's energy infrastructure division, according to CIMB analysts Roy Chen and William Tng, who cut their FY2016 earnings estimate for Boustead's energy arm by 36% to $15.2 million.

IPS Securex kept at 'buy' with target price of $1.26 by OSK-DMG

Stock Name: IPS Securex
Company Name: IPS SECUREX HOLDINGS LIMITED
Research House: OSK-DMGPrice Call: BUYTarget Price: 1.26



SINGAPORE (Dec 3): OSK-DMG is calling a buy on IPS Securex with a target price of $1.26.

In a Dec 3 report, analyst Jarick Seet says he is optimistic that IPS will clinch more contract wins and expand their product line in the near future.

Last night, IPS announced it has entered into a framework cooperation agreement with Bio-Nexus, which enables IPS to integrate Bio-Nexus's patented mobile workflow engine software platform into various solutions. IPS will also be the prime promoter to sell and market the solutions to Asean countries.